Mentalizing Minds Pllc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 302 Saunders Rd Ste 200, Riverwoods, IL 60015 Phone: 651-315-3410 |
Center For Holistic Medicine Counselor Medicare: Medicare Enrolled Practice Location: 240 Saunders Rd, Riverwoods, IL 60015 Phone: 847-236-1701 Fax: 847-236-1705 |
Center For Enriched Living Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 280 Saunders Rd., Riverwoods, IL 60015 Phone: 847-315-9888 Fax: 847-948-7621 |
Patzelt Psychology Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 302 Saunders Rd Ste 200, Riverwoods, IL 60015 Phone: 651-315-3410 |
Neurobehavioral Associates, P.c. Clinical Neuropsychologist Medicare: Medicare Enrolled Practice Location: 2033 Milwaukee Ave, Suite 334, Riverwoods, IL 60015 Phone: 303-520-0489 |
Holly Katz Counseling Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2416 Spyglass Hill Ct, Riverwoods, IL 60015 Phone: 847-452-7554 |
News Archive
Cedars-Sinai has partnered with the U.S. military to design the "operating room of the future" that will enable emergency medical teams to respond more quickly and effectively to patients with life-threatening injuries.
A pair of bills passed the Arizona Senate Thursday to prohibit public money for family-planning from going to organizations that give abortions and to allow some businesses to avoid paying for contraception for employees. Ariz. Gov. Jan Brewer also signed a bill banning most late-term abortions.
In a paper published in the current issue of the journal Molecular Biology and Evolution , Arizona State University biochemists Jason Raymond, Christopher Staples and Robert Blankenship and Rice University's Janet Siefert do an analysis of the genomes of a large group of bacteria and archaea, comparing in particular similar genes that produce the protein nitrogenase.
The National Council on Aging has formed a multi-year strategic alliance with DPS Health, a leader in clinically-proven online and mobile behavior change interventions for the emergent-risk population.
Halozyme Therapeutics, Inc. today announced that Roche has completed patient enrollment for the pivotal Phase 3 study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme's Enhanzeâ„¢ technology (rHuPH20, recombinant human hyaluronidase).
› Verified 7 days ago